Identification of a rare subset of adipose tissue-resident progenitor cells, which express CD133 and TRPC3 as a VEGF-regulated Ca2+ entry channel  by Poteser, Michael et al.
FEBS Letters 582 (2008) 2696–2702Identiﬁcation of a rare subset of adipose tissue-resident progenitor
cells, which express CD133 and TRPC3 as a VEGF-regulated Ca2+
entry channel
Michael Potesera, Annarita Graziania, Petra Edera, Ameli Yatesb, Heinrich Ma¨chlerb,
Christoph Romaninc, Klaus Groschnera,*
a Institute of Pharmaceutical Sciences, Pharmacology and Toxicology, Karl-Franzens-University of Graz, Graz, Austria
b Department of Cardiac Surgery, Medical University Graz, Graz, Austria
c Department of Biophysics, University of Linz, A-4020 Linz, Austria
Received 2 May 2008; revised 16 June 2008; accepted 26 June 2008
Available online 9 July 2008
Edited by Maurice MontalAbstract VEGF-induced Ca2+ signalling was investigated in
CD133+/VEGFR-2+ progenitor cells isolated from human adi-
pose stroma. Colonies derived from CD133+ immunoselected
cells displayed inhomogenous Ca2+ signals, with variable magni-
tude of VEGF-induced Ca2+ entry, which positively correlated
with expression of the Ca2+ channel protein TRPC3. High levels
of VEGF-induced Ca2+ entry and TRPC3 expression were pref-
erentially detected in rim areas of expanding colonies. Dominant
negative suppression of TRPC3 inhibited VEGF-induced
Ca2+entry into CD133+ cells. Our results identify TRPC3 as a
key Ca2+ entry channel in a subset of CD133+ stem cells. We
suggest TRPC3 as an essential determinant of cell fate in
CD133+ progenitor-derived colonies.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: CD133+; TRPC3; Ca2+ entry; Tissue-speciﬁc
progenitor cells; VEGF signalling; Adipose tissue1. Introduction
Tissue remodelling and regeneration has been suggested to
involve a rare subset of primitive, multipotent progenitor cells
that express the CD133 (AC133) surface antigen (reviewed in
[1]). The function of these adult stem cells is governed by a
variety of growth factors via as yet poorly understood cellular
mechanisms. Coexpression of CD133 with VEGFR-2 (KDR),
a prominent growth factor receptor involved in vasculogenesis,
along with expression of the stem cells marker CD34 has been
suggested as the typical ﬁngerprint feature of multipotent
hemangioblasts that can give rise to more diﬀerentiated endo-
thelial progenitor cells (EPCs) [2,3]. Nonetheless, the diﬀeren-
tiation potential of CD34+/CD133+/VEGFR-2+ cells is so far
incompletely understood. For VEGFR-2, coupling to cellular
Ca2+ homeostasis via phospholipase Cc (PLCc) [4] and/or gen-
eration of reactive oxygen species [5] is considered as a pivotal
signal transduction mechanism that mediates cellular re-
sponses to VEGF. The composition of signalling molecules in-
volved in such VEGF-mediated Ca2+ signalling processes,*Corresponding author. Fax: +43 316 380 9890.
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doi:10.1016/j.febslet.2008.06.049speciﬁcally with respect to Ca2+ entry pathways, is so far elu-
sive for immature adult stem cells.
TRPC proteins have recently emerged as a family of chan-
nel proteins that serve cellular signalling of a wide array of
phospholipase C coupled receptors including receptor tyro-
sine kinases such as growth factor receptors [6–8]. TRPC
channels, are likely governed by these receptor tyrosine ki-
nases via multiple cellular mechanisms [6,9] and have been
suggested as pivotal signalling molecules in mature vascular
cells and as key players in angiogenesis [10,11], while their
role in vascular progenitor cells and vasculogenesis is elusive.
Identiﬁcation of molecular components of growth factor re-
sponses in these immature progenitors appears of particular
importance in view of both the need for further delineation
of stem cell characteristics as well as for development of strat-
egies that allow for therapeutic interference with stem cell
function.
In the present study we report the expression of TRPC3,
a Ca2+ channel protein of the TRP family in a subpopulation
of CD133+ adipose tissue-resident stem cells. TRPC3 is
demonstrated as a signal transduction element that deter-
mines VEGF responses of immature CD133+ progenitor
cells.2. Methods
2.1. Cell preparation and culture
Mediastinal fat pads, routinely removed during heart surgery were
obtained from 40 to 80 year old patients of both sexes, following the
guidelines of the Austrian Ethics Commission (registration number
16-042). The tissue was freed from blood vessels and connective tis-
sue, minced with scalpel and exposed to a collagenase type II solu-
tion (from Clostridium histolyticum, 1.5 mg/ml) for 30–40 min at
37 C. The amount of digested fat varied in the samples obtained
from 2 to 20 ml. The fat tissue was centrifuged for 10 min at
1200 rpm (270 g) and the pellet was resuspended in PBS after remov-
ing the adipocyte-containing supernatant. The remaining cell suspen-
sion was sieved to eliminate undigested tissue and centrifuged again
for 5 min at 500–600 rpm (70 g). The typical total counts of cells
that could be obtained ranged between less then 104 to several
105. Finally, the cell pellet was suspended in culture media M199
containing VEGF (10 ng/ml, PeproTech EC., London, UK), plated
on ﬁbronectin coated petridishes and incubated at 37 C at 5%
CO2 and 80–90% relative humidity or subjected to ﬂow-cytometrical
analysis.blished by Elsevier B.V. All rights reserved.
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M450 Dynabeads goat antimouse IgG1 (Dynal AS, Oslo, Norway)
were washed twice with sterile PBS + 0.1% BSA and incubated with
monoclonal mouse IgG anti-human CD34 antibody (AC136, 43A1,
Biogen, Vienna, Austria) or mouse IgG anti-human CD133 (AC133,
Miltenyi Biotec, Bergisch-Gladbach, Germany) antibody (2 lg/mg) in
the presence of 1% BSA at 4 C for 30 min. Adipose tissue-derived stro-
mal vascular fractions were mixed with coated beads and incubated at
4 C for 20 min in a roller bath and ﬁnally sorted using a Magnetic Par-
ticle Concentrator (MPC, Dynal). Isolated cell populations were plated
on ﬁbronectin coated petridishes and cultured as described above.
2.3. Flow-cytometry
Vascular stromal cell preparations were washed with PBS and cen-
trifuged at 900 rpm (163 · g). For staining of extracellular epitopes
the cell surface proteins were blocked in suspension with 5% goat ser-
um (in PBS) and then incubated with the primary antibody. For stain-
ing of intracellular epitopes, cells were incubated with Fix & Perm
(An der Grub Bio Research Company, Kaumberg, Austria) ﬁxation
and permeabilization reagents for 15 min each. Cells were stained
and analyzed for phenotypic expression of surface markers using
mouse IgG anti-human CD34, CD133 (AC133), rabbit IgG anti-hu-
man TRPC3 (custom [12]), rabbit anti-human IgG VEGF Receptor
2 (Abcam Ltd., Cambridge, UK). The custom-made anti TRPC3
IgG was previously tested for speciﬁcity using the HEK293 expression
system [13]. Secondary antibodies used included goat anti-rabbit IgG
(FITC conjugate, Sigma, St. Louis, USA), rat anti-rabbit IgG (TRITC
conjugate, Sigma, St. Louis, USA), sheep anti-mouse IgG (FITC con-
jugate, Sigma, St. Louis, USA) and/or mouse anti human IgG R-PE
(monoclonal, BD Biosciences, Franklin Lakes, USA). Before counting,
cells were pelleted and washed with PBS. Cytometry was performed
using a CyFlow Space (Partec, Mu¨nster, Germany) ﬂow cell analyzer.
Quantiﬁcation, analysis and bleed-through correction was performed
using Partec FloMax Software.
2.4. Immunohistochemistry
Cells were seeded on ﬁbronectin coated coverslips and used for
immunoﬂuorescence staining after 24 or 48 h of culture. For staining
of intracellular epitopes, cells were washed, ﬁxated using a methanol
stabilized 3% formaldehyde solution (3.25 g Na2HPO4, 2 g NaH2PO4,
7.5 ml methanol, 50 ml formalin (37%), 500 ml H2O) and either perme-
abilized for 2 min with PBS containing 0.01% saponin before adminis-
tration of goat serum and antibodies or incubated with Fix&Perm.
Cells were incubated with primary antibodies at 37 C in PBS (pH
7.2) and 5% goat serum for 1 h. For staining of extracellular epitopes,
cells were ﬁxated as described above, incubated with 5% goat serum
and antibodies (see ﬂow-cytometry) in PBS (pH 7.2) at 4 C for 1 h.
After washing thrice with PBS the cells were then incubated with the
secondary antibodies for 1 h. Finally, the cells were washed with
PBS and preserved under sealed coverslips in mounting media (Mount-
ing Solution, Sigma). Microscopy was performed using an Axiovert
200M microscope (Zeiss, Go¨ttingen, Germany).
2.5. RT-PCR experiments
Total RNA was isolated using TRIZOL reagent (Invitrogen/Gib-
coBRL, Carlsbad, USA) from CD133+ immunoselected cells and re-
verse-transcribed (3 lg of total RNA) into ﬁrst-strand cDNA (cDNA
reverse transcription kit, Applied Biosystems). Primers used for PCR
and cycling conditions in order to amplify a TRPC3 speciﬁc fragment
(448 bp) have been described elsewhere [19]. A TRPC3 containing plas-
mid was used as positive control. The PCR products were visualised on
a 1.2% agarose gel containing ethidium bromide under UV light.
2.6. DNA constructs and adipose tissue stromal cell transfection
Cells were transiently transfected with an N-terminal fragment of
hTRPC3, EYFP-NTRPC3 (aa 1–302 of TRPC3), using Transfast
Transfection Reagent (Promega Corporation, Madison, WI, USA)
according to the manufacturers instructions.
2.7. Measurement of intracellular Ca2+
Adherent cells on coverslips were loaded with fura 2-AM (Molecular
Probes, OR, USA) for 30 min at 37 C. Subsequently, cells were
washed and subjected to ﬂuorescence imaging during constant perfu-sion with buﬀer containing either 137 mM NaCl, 5.4 mM KCl,
10 mM HEPES, 10 mM Glucose, 1 mM MgCl (nominally Ca2+-free)
or 137 mM NaCl, 5.4 mM KCl, 10 mM HEPES, 10 mM Glucose,
1 mM MgCl and 2 mM CaCl2 at room temperature. Excitation light
was supplied via a Polychrome II polychromator (TILL Photonics,
Gra¨felﬁng, Germany) and emission was detected by a Sensicam
CCD-camera (PCO Computer Optics, Kehlheim, Germany). Ca2+-sen-
sitive fura 2-AM ﬂuorescence was measured ratiometrically at 340 nm
and 380 nm excitation wavelength and emission was collected at
510 nm. Digital image recordings were analyzed using Axon Imaging
Workbench (Axon Instruments, Foster City, USA).2.8. Statistical analysis
Results were expressed as mean value ± S.E.M. Diﬀerences were
considered statistically signiﬁcant at P < 0.05 using Students t-test
for unpaired values.3. Results
3.1. Human retrosternal fat harbors a CD133+/VEGFR-2+ cell
population
Adipose stroma has been reported to contain progenitor
cells with vasoregenerative potential, including a small fraction
of CD133+ cells [14], representing immature potential cardio-
vascular progenitors. Flow-cytometry of freshly harvested vas-
cular stromal fractions obtained from retrosternal fat pads
revealed the presence of a low density population (2.9 ± 1.0,
N = 16) of CD133+ cells (Fig. 1A). Further characterization
of these cells demonstrated CD133+ as a subpopulation of
CD34+ cells with up to 58% of the CD34+ cells expressing
CD133 (55.5% ± 4.3, N = 3, not shown). Adipose tissue-resi-
dent CD133+ cells were found to express also VEGFR-2
(Fig. 1B). CD133+ cells amounted to about 10–30% of the
VEGFR-2+ (21% ± 4.5, N = 3) cells present in freshly isolated
vascular stromal fractions (Fig. 1C). Short-term culture (24–
48 h) of total vascular stromal preparations on ﬁbronectin gen-
erated CD133+ cell colonies. These CD133 colonies were
accompanied by a larger population of CD133 non colony-
forming, single cells, which displayed virtually no VEGFR-2
immunoreactivity. Culture of CD133+ cells that were isolated
from total adipose stromal fractions by magnetic bead assisted
cell sorting (MACS), similarly generated cell colonies within
24 h after plating (Fig. 1C). These cells display signiﬁcant
immunoreactivity for CD133 as well as VEGFR-2 (Fig. 1B
and C; N = 4). As a next step of characterization, we investi-
gated VEGF-induced Ca2+ signalling in CD133+and CD133
cells (Fig. 1D). Administration of VEGF in Ca2+-free condi-
tions induced a transient rise in cytoplasmic Ca2+ in
CD133+, as typically observed in response to mobilization of
Ca2+ from intracellular Ca2+ pools along with a pronounced,
sustained promotion of cellular Ca2+ entry upon elevation of
extracellular Ca2+ to 2 mM (classical Ca2+ re-addition proto-
col). By contrast, CD133 cells lacked responses to VEGF
and displayed only essentially slow and delayed elevation of
cytoplasmic Ca2+ upon Ca2+ re-addition. Further character-
ization of Ca2+ signalling in CD133+ cell colonies revealed
Gd3+ sensitivity of the VEGF-activated Ca2+ entry pathway.
As illustrated in Fig. 1E, VEGF-induced Ca2+ entry was
strongly suppressed by Gd3+ (100 lM), a condition that typi-
cally inhibits TRPC3/6/7 channels [15,16]. These results sub-
stantiate that CD133+ cell colonies express a VEGFR that
determines Ca2+ homeostasis and promotes depletion of cellu-
lar Ca2+ stores as well as Ca2+ entry. Thus, human retrosternal
Fig. 1. Characterization of a human adipose tissue-derived CD133+/VEGFR-2+cell population. (A) Representative (N = 4) cytometrical
quantiﬁcation (forward-scatter vs. ﬂuorescence intensity) of CD133 (AC133)-bright cells within adipose tissue stromal preparations. Relative size
of the CD133+ population is given on top (2%). (B) CD133 (AC133)-bright cells represent a subpopulation (29%) of the VEGF-receptor type 2
(VEGFR-2) expressing fraction. (C) Immunocytochemical characterization of a cell cluster at 24 h after plating of CD133+ immunoselected cells.
Stainings with anti-CD133 (AC133, left) and anti-VEGFR-2 (right) are shown. Bar represents 20 lm. (D) VEGF-induced Ca2+ signalling in CD133+
cell clusters (circles, N = 24) and in CD133-dim non-clustered cells (CD133, triangles, N = 18). (E) VEGF-induced Ca2+-signalling in CD133+ cell
clusters in the absence (circles, N = 50) and presence of 100 lM Gd3+ (triangles, N = 53). Gd3+ was added after 200 s recording. (D and E) Time
courses of fura-2 Ca2+ imaging are shown (means ± S.E.M.). Cells were challenged in nominally Ca2+-free solution with VEGF to discharge of Ca2+
stores and Ca2+ entry was initiated by readdition of extracellular Ca2+ (2 mM) as indicated.
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the stem cell marker CD133 along with functional VEGFR-2.
3.2. A subpopulation of adipose tissue-resident CD133+ cells
expresses the Ca2+ channel protein TRPC3
The observation of a VEGF-induced, Gd3+ sensitive Ca2+
entry pathway in CD133+ cells is consistent with involvement
of phospholipase C-regulated channels of the TRPC family as
downstream signalling eﬀectors of VEGFR-2 and prompted us
to test for TRPC expression. Immunocytochemical experi-
ments with CD133+ cells after short term (24 h) culture
(Fig. 2A) demonstrated prominent expression of TRPC3, a
putative phospholipase C and redox-dependent cation channel
subunit, in a subpopulation of the expanding cell clusters.Other members of the TRPC family such as TRPC1, TRPC4
and TRPC6 were barely detectable by immunostaining (not
shown). The expression of TRPC3 in CD133+ cells was further
conﬁrmed at the mRNA level by RT-PCR experiments in
immunoselected, CD133+ cells (Fig. 2B). Cytometrical analysis
of freshly isolated stroma preparations revealed that TRPC3+
cells represent a subpopulation of the CD133+ cell fraction
(Fig. 2C).
3.3. Expression of the Ca2+ channel protein TRPC3 as the basis
of heterogeneity in VEGF signalling within developing cell
clusters
Cell colonies derived from CD133 immunoselected cells after
prolonged culture (>48 h) displayed a striking heterogeneity in
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sion. As TRPC3 immunoreactivity was predominantly high
in margin areas of larger cell colonies (Fig. 3A), we set out
to test for a possible role of this heterogeneity as the basis of
heterogenous VEGF responses. Ca2+ imaging experiments
were performed in cell colonies displaying distinct areas of
high and low TRPC3 immunoreactivity. As shown in
Fig. 3B–D, cell populations with low TRPC3 expression (cen-
tral area of colonies) displayed signiﬁcantly lower Ca2+ re-
sponses as compared to populations with high TRPC3
expression that were typically found in the margin of colonies.
Moreover, in cell colonies that exhibited less distinct separa-
tion of cells with diﬀerent TRPC3 expression, we analyzed
the relation between VEGF-induced Ca2+ entry and TRPC3
channel expression at a single cell basis. These experiments re-
vealed a signiﬁcant positive correlation as illustrated in
Fig. 3E. These ﬁndings suggest that TRPC3 is a key determi-
nant of VEGF responses and Ca2+ signalling in CD133+ pro-
genitor cells.
3.4. TRPC3 is a signalling molecule that mediates VEGF-
induced Ca2+ entry into CD133+ cells
To further test for a role of TRPC3 in VEGF-dependent
Ca2+ signalling of CD133+ cells we employed an established
dominant negative knock-down strategy [12]. CD133 immu-
noselected cells were transfected to express a TRPC3 fragment
(NTRPC3) fused to YFP. Fragments of the cytosolic N-termi-
nus of TRPCs, which has been identiﬁed as an interaction do-
main essential for the formation of pore complexes, exert a
dominant negative inhibitory eﬀect due to interference withFig. 2. A subpopulation of adipose tissue-resident CD133+ progenitor cells e
double-staining of an adipose tissue-derived cell colony, 24 h after plating of C
and anti-TRPC3 (right) are shown. CD133-antibody coated beads (arrow) a
(left) while invisible in micrographs displaying TRITC ﬂuorescence for T
expression in cell cultures at 48 h after plating of CD133+ immunoselecte
Representative (N = 3) cytometrical analysis of CD133- and TRPC3-brightchannel assembly [17,18]. This dominant negative interaction
has repeatedly been utilized to identify native TRPC conduc-
tances [13,19]. Expression of the dominant negative TRPC3-
YFP fusion protein was clearly detectable in single CD133+
cells by ﬂuorescence microscopy within 24–48 h after transfec-
tion as shown in Fig. 4A. A comparison of Ca2+ entry into
CD133+ cells, which either expressed or lacked NTRPC3
expression, is illustrated in Fig. 4B and C. VEGF-induced rises
in intracellular Ca2+ initiated upon Ca2+ re-addition to
CD133+ cells were signiﬁcantly inhibited by expression of
NTRPC3 (Fig. 4D) indicating an essential contribution of this
channel protein to Ca2+ entry into CD133 cells.4. Discussion
With our current study, we demonstrate the presence of a
small population of immature CD133+/VEGFR-2+ stem/pro-
genitor cells in human retrosternal adipose stroma. A subpop-
ulation of these cells expresses the cation channel protein
TRPC3.
Adipose vascular stroma has been proposed to host a signif-
icant fraction of proangiogenic stem/progenitor cells
[14,20,21]. Small fractions (about 2–5%) of adipose vascular
stroma were reported to express the speciﬁc stem cells marker
CD133 (AC133) [14], which has been suggested to identify
rather immature and highly proliferative stem cell populations.
Detailed properties of these adipose tissue-resident CD133+
cells have so far not been reported. Analysis of the expression
of stem cells markers in freshly isolated cells from human ret-xpresses the channel protein TRPC3 (A) Fluorescence micrographs of
D133+ immunoselected cells. Stainings with anti-CD133 (AC133, left)
re still present and visible as stained by the FITC-secondary antibody
RPC3 (right). Bar represents 20 lm. (B) PCR detection of TRPC3
d cells. TRPC3 cDNA clone served as reference (control, left). (C)
cells in freshly adipose tissue-derived stromal cells.
Fig. 3. VEGF-induced Ca2+-entry in CD133+ cells is correlated with TRPC3 expression (A) Immunocytochemical staining of TRPC3 in a cell
clusters derived from human adipose tissue, 48 hours after seeding. Central areas show spare TRPC3-expression (1) as compared to the rim area of
the cell cluster (2). Bar represents 20 lm. (B) Intensity/color-coded fura-2 calcium images of the cell cluster depicted in A, during a Ca2+ imaging
experiment performed before the immunostaining. Left: VEGF-stimulated cluster showing fairly homogenous low [Ca]i values (magenta, dark blue)
before readdition of Ca2+. Right: Same cluster after readdition of Ca2+. Central areas (1) of the cell colony preserve lower [Ca]i values (blue) while
TRPC3-rich rim area displays pronounced Ca2+entry (2). (C) Time course of VEGF-stimulated Ca2+-entry as determined by fura-2 imaging in rim
and center areas the cell cluster depicted in A and B. Cells in the center of the cluster (1) show signiﬁcantly smaller VEGF-induced Ca2+-entry than
TRPC3-expressing cells of the rim area (2). Representative of four clusters. (D) Statistical comparison of VEGF responses in center and rim areas of
cell clusters that displayed a high TRPC3 rim region. Baseline intracellular Ca2+levels (base) as well as VEGF-induced Ca2+ release in nominally
Ca2+-free solution (+VEGF) and readdition-induced Ca2+ entry (+Ca2+) is shown. N = 39. Asterisks indicate statistically signiﬁcant diﬀerences
(P < 0.05).(E) TRPC3 expression levels of individual cells as determined by immunostaining (y-axis) are plotted against the corresponding VEGF-
induced Ca2+ entry signals derived from fura-2 ﬂuorescence measurements (x-axis) in cells that were unequivocally reassigned in four diﬀerent
clusters.
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presses CD133 (<5%). This level of CD133 expression in retro-
sternal fat is consistent with that reported for other white
human adipose tissues [14,22]. Both ﬂow-cytometry and immu-
nocytochemical experiments demonstrated that CD133+ cells
represent a subpopulation of CD34+ cells and provided evi-
dence for expression of VEGFR-2 in the CD34+/CD133+ pop-
ulation. Thus, we show for the ﬁrst time that human adipose
tissue harbors a cell population that may contribute to the pre-
viously observed proangiogenic potential of adipose stromal
cell fractions, as this combination of cell surface markers has
been suggested to identify endothelial progenitor cells
[2,3,23,24]. Nonetheless, the density of these cells is essentially
low, and the general ability of CD34+/CD133+/VEGFR-2+
cells to generate endothelial progeny has recently been ques-
tioned [25]. In view of the multipotent nature of CD133+ cells,
the contribution of these cells to previously reported promo-
tion of tissue regeneration by adipose stromal fractions as well
as the true diﬀerentiation potential of these cells remains to be
clariﬁed.
The here identiﬁed tissue-resident CD133+/VEGFR-2+ cells
were clearly heterogenous and have been shown to comprise
subpopulations that display divergent cellular responses to
VEGF due to diﬀerential expression of the membrane protein
TRPC3. We consider this ﬁnding as an important step to
understand the mechanisms that control the fate of rare, prim-
itive stem/progenitor cells. The TRPC3 channel protein is typ-
ically involved in Ca2+ signalling processes that are governed
by the phospholipase C/store-depletion pathway [16] and hasalso been found to form channel complexes that mediate cellu-
lar redox signals [12,26]. Members of the TRPC channel family
including TRPC3 have been suggested as important down-
stream targets of VEGF signalling [7,12,27]. It is important
to note that several cellular processes may link TRPC channel
activity to growth factor signalling. For TRPC3, a most likely
mechanism is PLCc-mediated formation of diacylglycerol,
which is known to activate TRPC3/6/7 channels [28]. Nonethe-
less, activation by a store-dependent mechanism that involves
interactions with STIM and Orai proteins, may be considered
as well [29]. Moreover, in view of the previously reported sen-
sitivity of TRPC3 channels to redox stress [12,19], it appears
reasonable to speculate that control of TRPC3 via VEGF
may involve generation of reactive oxygen species and changes
in cellular redox state, which typically occurs in response to
VEGFR activation [5]. Thus, the cellular processes involved
in activation of TRPC3 in CD133+ progenitors remain to be
clariﬁed.
TRPC3 is expressed in mature cardiovascular cells, typically
at rather low levels in normal, healthy tissues and was reported
to increase speciﬁcally during pathophysiological remodelling
in the cardiovascular system [30]. We have previously demon-
strated that TRPC3 is involved in a cation conductance that is
activated in response to oxidative stress in macrovascular
endothelial cells [12,19]. Although TRPC3 expression has
repeatedly been demonstrated in large blood vessels as well
as in the heart, its relative abundance in comparison to other
TRPC species was found rather low in mature microvas-
cular cells [31] including human microvascular endothelium
Fig. 4. VEGF-induced Ca2+-entry into CD133+ cells is inhibited by expression of a TRPC3-dominant negative fragment. (A) Intensity/color-coded
representation of a ﬂuorescence-microscopical image showing two NTRPC3-YFP-expressing cells (white circles, right) and two NTRPC3-YFP-dim
cells (white circles, left) in the rim area of an adipose tissue-derived stromal cell cluster. Bar represents 20 lm (B and C) Intensity/color-coded fura-2
calcium images showing the same area as depicted in A, in the presence of VEGF before (B) and after (C) readdition of Ca2+ in the bath-solution.
NTRPC3-YFP-negative cells rapidly take up Ca2+, while cells expressing the dominant negative fragment of TRPC3 remain at low [Ca2+]i levels. (D)
Time course of fura-2 Ca2+ imaging. Cells were challenged in nominally Ca2+-free solution with VEGF to discharge of Ca2+ stores and Ca2+ entry
was initiated by readdition of extracellular Ca2+ (2 mM) as indicated (N = 19). Cells expressing a functional dominant negative fragment of TRPC3
(open circles) are compared with control cells (ﬁlled circles). Representative of four experiments. Time courses during Ca2+ readdition were
signiﬁcantly diﬀerent (P < 0.05).
M. Poteser et al. / FEBS Letters 582 (2008) 2696–2702 2701(Groschner, K. and Graziani, A., unpublished observation).
Interestingly, we observed a high level of TRPC3 expression
exclusively in CD133+ cells isolated from adipose vascular
stroma, while TRPC3 was virtually absent in other cell popu-
lations. It is of note that CD133 populations derived by
short-term culture of adipose stroma preparations not only
lacked TRPC3 expression but in addition failed to display sig-
niﬁcant VEGF-induced Ca2+ signals. Hence, our results sug-
gest a particular role of TRPC3 channels in Ca2+ signalling
of immature stem/progenitor cells. Another striking ﬁnding
was that high TRPC3 expression was detected exclusively in
a subset of CD133+ cells. A comparison of VEGF-induced
Ca2+ signalling in CD133+ cells displaying diﬀerent levels of
TRPC3 expression as well as experiments using transient
expression of dominant negative channel fragment identiﬁed
TRPC3 as a marker for cells that display signiﬁcantly en-
hanced Ca2+ entry signals upon challenge with VEGF. During
in vitro proliferation of CD133+ cell colonies, we observed a
tendency for segregation of TRPC3-low and TRPC3-high
expressing cells with a clear preference of TRPC3 expression
in the outer rim area of larger colonies. It is tempting to spec-
ulate about a speciﬁc role of TRPC3 signalling in the function
of progenitor cells in the state forming the front of an expand-
ing cell cluster. Proliferating, immature cells in the rim regionof expanding stem cell colonies have previously been shown to
display distinct cellular properties [32]. This observation is line
with our ﬁnding of accentuated VEGF-induced Ca2+ signalling
and expression of the Ca2+ channel TRPC3 in these cells. Our
present results prompt future studies to delineate the exact
physiological role of TRPC3 in stem cell fate and function.
In aggregate, we report the expression of the Ca2+ channel
protein TRPC3 in a rare, adipose tissue-resident population
of CD133+/VEGFR-2+ cells and demonstrate the functional
signiﬁcance of this protein as a determinant of VEGF signal-
ling in these cells. Our results suggest TRPC3 as an important
component of cellular signalplexes in CD133+ cells and as a
potential target for strategies to control these cells function
and fate.
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